FSTL1 promotes M2 polarization of macrophages via the DIP2A–Smad2/3 Axis in gastric cancer
It is indicated that FSTL1 represents a promising immunomodulatory target and highlight its potential as a therapeutic target to reprogram the immunosuppressive microenvironment and improve the efficacy of GC immunotherapy.